These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31951003)

  • 41. Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis.
    Tada M; Doi H; Koyano S; Kubota S; Fukai R; Hashiguchi S; Hayashi N; Kawamoto Y; Kunii M; Tanaka K; Takahashi K; Ogawa Y; Iwata R; Yamanaka S; Takeuchi H; Tanaka F
    Am J Pathol; 2018 Feb; 188(2):507-514. PubMed ID: 29128563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.
    Brettschneider J; Arai K; Del Tredici K; Toledo JB; Robinson JL; Lee EB; Kuwabara S; Shibuya K; Irwin DJ; Fang L; Van Deerlin VM; Elman L; McCluskey L; Ludolph AC; Lee VM; Braak H; Trojanowski JQ
    Acta Neuropathol; 2014 Sep; 128(3):423-37. PubMed ID: 24916269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.
    Cykowski MD; Takei H; Schulz PE; Appel SH; Powell SZ
    Acta Neuropathol Commun; 2014 Dec; 2():171. PubMed ID: 25539830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.
    Shellikeri S; Myers M; Black SE; Abrahao A; Zinman L; Yunusova Y
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):385-395. PubMed ID: 31088163
    [No Abstract]   [Full Text] [Related]  

  • 49. Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia.
    Takeuchi R; Toyoshima Y; Tada M; Tanaka H; Shimizu H; Shiga A; Miura T; Aoki K; Aikawa A; Ishizawa S; Ikeuchi T; Nishizawa M; Kakita A; Takahashi H
    Brain Pathol; 2016 Jan; 26(1):82-94. PubMed ID: 25787090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
    Toyoshima Y; Takahashi H
    Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
    Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.
    Coan G; Mitchell CS
    Neurodegener Dis; 2015; 15(5):301-12. PubMed ID: 26183171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
    Smethurst P; Sidle KC; Hardy J
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PCBP2 Is Downregulated in Degenerating Neurons and Rarely Observed in TDP-43-Positive Inclusions in Sporadic Amyotrophic Lateral Sclerosis.
    Yoshimura M; Honda H; Sasagasako N; Mori S; Hamasaki H; Suzuki SO; Ishii T; Ninomiya T; Kira JI; Iwaki T
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):220-228. PubMed ID: 33313661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.